MAIA Biotechnology (MAIA) Non-Current Assets (2021 - 2026)

MAIA Biotechnology (MAIA) has reported Non-Current Assets for 6 consecutive years, with $2800.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets changed 0.0% year-over-year to $2800.0 in Q2 2026; TTM through Jun 2026 was $40203.0, a 258.96% increase from a year earlier, with the FY2025 full-year figure at $2800.0, changed 0.0% from the prior year.
• Non-Current Assets was $2800.0 for Q2 2026 at MAIA Biotechnology, down from $7518.0 in the prior quarter.
• Over five years, Non-Current Assets peaked at $1.2 million in Q2 2022 and troughed at $2800.0 in Q3 2022.
• A 5-year average of $178866.7 and a median of $2800.0 in 2022 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 13040.71% in 2023 and plunged 99.43% in 2024, its largest moves.
• Over 5 years, Non-Current Assets stood at $214003.0 in 2022, then tumbled by 98.69% to $2800.0 in 2023, then changed by 0.0% to $2800.0 in 2024, then changed by 0.0% to $2800.0 in 2025, then changed by 0.0% to $2800.0 in 2026.
• The last three Non-Current Assets figures came in at $2800.0 (Q2 2026), $7518.0 (Q1 2026), and $2800.0 (Q4 2025), per Business Quant data.